• DOI:10.1007/s10549-008-0005-6
Corpus ID: 7302079

Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer

@article{Perez2008ImpactMA,
  title={Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer},
  author={E. Perez},
  journal={Breast Cancer Research and Treatment},
  year={2008},
  volume={114},
  pages={195-201}
}

• E. Perez
• Published 2008
• Medicine
• Breast Cancer Research and Treatment

Despite advances in treatment of patients with metastatic breast cancer (MBC), prognosis remains poor and median survival is 2–3 years. Resistance to antineoplastics mediated by many factors, potentially including overexpression of drug efflux proteins or altered β-tubulin isotype expression limits the effectiveness of MBC chemotherapy. Capecitabine, approved for anthracycline- and taxane-resistant MBC, has produced modest responses, highlighting the need for more effective treatments for MBC… Expand